Journal of Neurochemistry | 2021

Clusterin inhibits Aβ42 aggregation through a “strawberry model” as detected by FRET‐FCS

 
 
 
 
 
 
 
 
 
 
 
 
 

Abstract


Extracellular plaque deposits of β‐amyloid peptide (Aβ) are one of the main pathological features of Alzheimer s disease (AD). The aggregation of Aβ42 species, especially Aβ42 oligomers, is still an active research field in AD pathogenesis. Secretory clusterin protein (sCLU), an extracellular chaperone, plays an important role in AD pathogenesis. Although sCLU interacts directly with Aβ42 in vitro and in vivo, the mechanism is not clear. In this paper, His‐tagged sCLU (sCLU‐His) was cloned, expressed and purified, and we applied florescence resonance energy transfer‐fluorescence correlation spectroscopy (FRET‐FCS) to investigate the direct interaction of sCLU‐His and Aβ42 at the single‐molecule fluorescence level in vitro. Here, we chose four different fluorescently labeled Aβ42 oligomers to form two different groups of aggregation models, easy or difficult to aggregate. The results showed that sCLU‐His could form complexes with both aggregation models, and sCLU‐His inhibited the aggregation of Aβ42/RB ~ Aβ42/Atto647 (easy to aggregate model). The complexes were produced as the Aβ42/Label adhered to the sCLU‐His, which is similar to a “strawberry model,” as strawberry seeds are dotted on the outer surface of strawberries. This work provided additional insight into the interaction mechanism of sCLU and Aβ42.

Volume 158
Pages 444 - 454
DOI 10.1111/jnc.15344
Language English
Journal Journal of Neurochemistry

Full Text